SeraCare Divests Biorepository, Biobanking Businesses | GenomeWeb

NEW YORK (GenomeWeb News) – SeraCare Life Sciences announced late on Thursday a reorganization of its business after selling off certain segments.

The Milford, Mass.-based firm sold its biorepository, biobanking, and laboratory services business to Precision Health Holdings for an undisclosed amount and restructured its operations into three units — IVD Research, IVD Processing, and Clinical Laboratory.

The new structure of the company, it said, will "deliver greater insight into customer needs while streamlining business processes."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.